Abstract 2845
Background
Adolescents and young adults (AYA) with cancer represent a unique demographic with distinctive developmental and psychosocial pressures. We sought to understand the baseline psychosocial needs of AYAs compared to case matched older adults at diagnosis using the Canadian Problem Checklist (CPC) and the Psychosocial Screen for Cancer - Revised (PSSCAN-R). The CPC is a tool to identify patient concerns in six domains: emotional, practical, spiritual, social, informational and physical. The PSSCAN-R is a validated tool to assess psychosocial needs and distress.
Methods
All AYA patients who completed the CPC and PSSCAN-R within 6 months of their cancer diagnosis between 2011-2016 in the province of British Columbia, Canada were included in the study. Baseline demographics were collected through retrospective chart review. A 3:1 case match based on gender, primary tumor site and metastatic status was performed with older adults (>40 years old) and AYA (18-40 years old). Statistical analysis was undertaken through Chi squared and Fisher’s exact test.
Results
2045 AYAs were case matched by common AYA tumor sites with 6050 older adults. Top five tumor sites were breast (20.4%), lymphoma (11.5%), gastrointestinal (10.8%), thyroid (10.6%), cervix/endometrium (8.0%). 61.9% were female and 12.1% had metastatic disease at diagnosis. The top 6 concerns for AYAs (% AYA, % older adults) were: fear/worry (56.6, 42.9) understanding of illness (47.6, 41.4), sleep (35.2, 28.9), sadness (34.1, 20.0), finances (33.8, 15.0), school/work (33.7, 10.5), all p < 0.01. AYAs reported higher anxiety at baseline (% AYA, % older adults): subclinical (26.0, 19.9), clinical (26.6, 17.1), p < 0.01.
Conclusions
Significant differences in baseline psychosocial needs for AYAs exist across multiple domains. Specifically, higher emotional, financial, school/work distress and baseline anxiety scores. Tailored support with early focus on these domains would benefit this unique and under-served population.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
3309 - Heat Shock Protein 90 chaperones and Protein Kinase D3 regulates androgen-independent prostate cancer development
Presenter: Attila Varga
Session: Poster Display session 1
Resources:
Abstract
3441 - The SWI/SNF driven reprograming for the AR cistrome is NSD2 dependent
Presenter: Katia Ruggero
Session: Poster Display session 1
Resources:
Abstract
1659 - IGF1R inhibition affects the survival of HT29 cancer cells by alterations of the TLR9- and autophagy signaling
Presenter: Györgyi Műzes
Session: Poster Display session 1
Resources:
Abstract
1379 - Characterization of atypical dMMR (deficient MisMatch Repair) tumors: a study from a large cohort of 4948 cases
Presenter: Marion Jaffrelot
Session: Poster Display session 1
Resources:
Abstract
1657 - Modulation of TLR9-dependent autophagy response via inhibition of c-Met signaling influences the survival of HT29 cancer cells
Presenter: Ferenc Sipos
Session: Poster Display session 1
Resources:
Abstract
3045 - Positive Feedback Activation of Notch Signal by Obesity Enhances Colorectal Tumorigenicity
Presenter: Dake Chu
Session: Poster Display session 1
Resources:
Abstract
2285 - The Pathological and Functional Roles of BRPF1 in Hepatocellular Carcinoma
Presenter: Lai Hung Carol Cheng
Session: Poster Display session 1
Resources:
Abstract
3210 - Protein tyrosine phosphatase non-receptor type 3 (PTPN3) could be a new therapeutic target for pancreatic cancer.
Presenter: Akio Yamasaki
Session: Poster Display session 1
Resources:
Abstract
3920 - A Novel bispecific BCMAxCD3 T cell engaging antibody that treat multiple myeloma (MM) with minimal cytokine serection
Presenter: Zhenyu Li
Session: Poster Display session 1
Resources:
Abstract
2691 - Quantitative spatial profiling of lymphocyte-activation gene 3 (LAG-3)/major histocompatibility complex class II (MHC II) interaction in gastric and urothelial tumors
Presenter: Cyrus Hedvat
Session: Poster Display session 1
Resources:
Abstract